Delcath Systems to Host Third Quarter 2026 Earnings Call

What happened

Delcath Systems will host a conference call on November 9, 2026, at 8:30 AM Eastern Time to discuss results for its third quarter ended September 30, 2026.

Confirmed

Global impact / market context

Quarterly results will show how much revenue Delcath earns from its liver cancer products and whether spending is under control. Investors use the call to judge cash available and the path toward profit.

Analyst inference

Delcath is a small interventional oncology company whose products deliver high-dose chemotherapy to the liver while limiting exposure to the rest of the body. Its results carry more weight because it depends on a narrow product line.

Analyst inference

What to watch

1. The call starts November 9, 2026, at 8:30 AM Eastern Time, and a replay will be archived on the company's website shortly after the call ends. Confirmed
2. Listen for whether management gives sales guidance for HEPZATO KIT, which is a combination drug and device product in the United States. Proposed
3. Watch spending on the sales force and procedures, because higher costs would reduce cash available before the company reaches steady profit. Analyst inference

Evidence

• Original source link unavailable